RxDoctor Payments Data

Stephanie McClenny, APRN

Nurse Practitioner · Wichita, KSNPI 1093476574

Payments from drug & device makers

$1,493in general payments, 2019–2025

Across 58 payments — averaging $25.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$274
  • Dendreon Pharmaceuticals LLC$259
  • Astellas Pharma US Inc$199
  • Teleflex LLC$136
  • Sumitomo Pharma America, Inc.$115
  • Axonics, Inc.$80
  • plus $429 from 13 others

What the payments were for

  • Food & beverage$1,13276%
  • Education$36124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,493 in reported general payments places this provider in the 80th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$116,924
Medicare patients
935
Services billed
11,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron126$59,794
GemtesaVibegron76$39,604
Estradiol63$4,626
Methenamine Hippurate56$2,388
Potassium Citrate ErPotassium Citrate59$2,252
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst103$1,706
Tamsulosin Hcl210$1,450
Testosterone Cypionate25$680
Cephalexin92$623
Finasteride44$393
Oxybutynin Chloride37$281
Ciprofloxacin Hcl31$236
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim58$227
Solifenacin Succinate11$189
Oxybutynin Chloride ErOxybutynin Chloride19$184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$199$59,794126 claims
Sumitomo Pharma America, Inc.Gemtesa$115$39,60476 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →